Skip to main content

Sofinnova Investments, Inc.

13F filer · CIK 0001631134
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$1.93BU.S. long equity reported on 13F
Positions5311 new · 19 closed
Net flow last quarter-$425MBuys minus sells
Top 10 positions weight57.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202653 positions
NTRANatera, Inc.$421M21.76%1.08%Not reportedQ1 2018
VERAVera Therapeutics, Inc.$120M6.20%3.89%Not reportedQ2 2021
GMABGenmab A/S$111M5.74%Not reported+437.7%Q1 2026
JAZZJazz Pharmaceuticals plc$88M4.55%0.58%-38.9%Q2 2020
RAPPRapport Therapeutics, Inc.$79.4M4.10%3.97%Not reportedQ2 2024
SPTXSeaport Therapeutics, Inc.$77.4M4.00%6.66%NewQ2 2026
AVBPArriVent BioPharma, Inc.$58.9M3.05%3.51%Not reportedQ1 2024
RAREUltragenyx Pharmaceutical Inc.$57.3M2.96%1.74%-45.4%Q4 2025
BIOABioAge Labs, Inc.$56.2M2.91%5.01%Not reportedQ3 2024
BMYBristol Myers Squibb Co$50.5M2.61%0.04%-55.9%Q1 2018
SUPNSupernus Pharmaceuticals, Inc.$48.2M2.49%1.78%+8.6%Q2 2020
RYTMRhythm Pharmaceuticals, Inc.$45.3M2.34%0.59%-9.4%Q2 2018
GILDGilead Sciences, Inc.$43.3M2.24%0.03%Not reportedQ4 2018
UTHRUNITED THERAPEUTICS Corp$41.4M2.14%0.18%-52.2%Q3 2019
COGTCogent Biosciences, Inc.$40.1M2.07%0.60%-51.0%Q1 2024
AXSMAxsome Therapeutics, Inc.$39.3M2.03%0.31%-24.6%Q1 2020
IMTXImmatics N.V.$37.2M1.92%2.74%+1.1%Q3 2020
DYNDyne Therapeutics, Inc.$36.8M1.90%1.00%+1.5%Q2 2023
IMNMImmunome Inc.$36.5M1.88%1.52%+1.1%Q1 2024
IDYAIDEAYA Biosciences, Inc.$34.5M1.78%0.96%-18.3%Q3 2022
ANABAnaptysbio, Inc$33.3M1.72%1.70%+32.5%Q3 2018
NKTRNektar Therapeutics$32.9M1.70%2.32%-7.4%Q3 2025
PHVSPharvaris N.V.$30.5M1.58%1.35%+7.7%Q4 2023
RCUSArcus Biosciences, Inc.$29.2M1.51%0.74%+2.5%Q4 2020
INBXInhibrx Biosciences, Inc.$28.7M1.48%2.06%-25.4%Q4 2021
BMRNBiomarin Pharmaceutical Inc$20.5M1.06%0.19%-54.2%Q4 2018
MANEVeradermics, Inc$18.3M0.95%0.36%+103.2%Q1 2026
ALCAlcon Inc$17.2M0.89%0.05%-65.0%Q4 2025
INSMINSMED Inc$16.9M0.87%0.07%-54.2%Q1 2019
EWTXEdgewise Therapeutics, Inc.$15.5M0.80%0.35%-1.4%Q2 2024
NRIXNurix Therapeutics, Inc.$12.7M0.66%0.51%NewQ2 2026
DSGNDesign Therapeutics, Inc.$12.5M0.65%1.38%NewQ2 2026
DFTXDefinium Therapeutics, Inc.$12M0.62%0.19%-25.7%Q1 2026
TRAXFirst Tracks Biotherapeutics, Inc.$11.4M0.59%1.60%NewQ2 2026
ABTAbbott Laboratories$11.2M0.58%0.01%NewQ2 2026
IRONDisc Medicine, Inc.$10.7M0.55%0.38%+86.7%Q1 2024
TENXTenax Therapeutics, Inc.$7.28M0.38%1.57%+379.0%Q1 2026
SIONSionna Therapeutics, Inc.$6.35M0.33%0.32%NewQ2 2026
ABSIAbsci Corp$3.91M0.20%0.22%NewQ2 2026
MIRMMirum Pharmaceuticals, Inc.$3.23M0.17%0.04%Not reportedQ1 2020
JBIOJade Biosciences, Inc.$2.39M0.12%0.17%Not reportedQ2 2025
SVRASavara Inc$2.25M0.12%0.18%Not reportedQ2 2018
PRAXPraxis Precision Medicines, Inc.$2.16M0.11%0.02%-89.9%Q1 2025
SEPNSepterna, Inc.$1.59M0.08%0.10%Not reportedQ1 2026
OKUROnKure Therapeutics, Inc.$1.47M0.08%0.80%+127.0%Q1 2026
SGMTSagimet Biosciences Inc.$1.29M0.07%0.54%NewQ2 2026
WVEWave Life Sciences, Inc.$1.1M0.06%0.10%Not reportedQ2 2025
AKTSAktis Oncology, Inc.$1.05M0.05%0.06%NewQ2 2026
TYRATyra Biosciences, Inc.$1.03M0.05%0.05%-84.2%Q1 2026
BOLTBolt Biotherapeutics, Inc.$530K0.03%7.15%Not reportedQ1 2021
Q1 2026Reported May 15, 202661 positions
NTRANatera, Inc.$310M11.78%1.09%Not reportedQ1 2018
BMYBristol Myers Squibb Co$121M4.58%0.10%+31.4%Q1 2018
JAZZJazz Pharmaceuticals plc$113M4.30%0.97%-37.7%Q2 2020
VERAVera Therapeutics, Inc.$112M4.27%4.37%Not reportedQ2 2021
UTHRUNITED THERAPEUTICS Corp$94.9M3.61%0.38%+1.5%Q3 2019
AZNAstrazeneca PLC$89.9M3.42%Not reported-44.1%Q1 2018
COGTCogent Biosciences, Inc.$81.4M3.09%1.24%+7.1%Q1 2024
RAREUltragenyx Pharmaceutical Inc.$65.9M2.50%3.20%+3676.6%Q4 2025
RAPPRapport Therapeutics, Inc.$59.6M2.26%3.98%Not reportedQ2 2024
INSMINSMED Inc$56.6M2.15%0.16%+120.7%Q1 2019
ALCAlcon Inc$55M2.09%0.15%+119.5%Q4 2025
SUPNSupernus Pharmaceuticals, Inc.$49.3M1.87%1.64%+72.5%Q2 2020
BMRNBiomarin Pharmaceutical Inc$44.2M1.68%0.40%+12.2%Q4 2018
BIIBBiogen Inc.$42.1M1.60%0.16%Not reportedQ4 2019
CELCCelcuity Inc.$41.8M1.59%0.76%+22.3%Q3 2025
BIOABioAge Labs, Inc.$40.1M1.52%5.17%Not reportedQ3 2024
RYTMRhythm Pharmaceuticals, Inc.$39.1M1.49%0.66%+65.9%Q2 2018
AVBPArriVent BioPharma, Inc.$39.1M1.49%3.74%Not reportedQ1 2024
IDYAIDEAYA Biosciences, Inc.$37.7M1.43%1.29%+27.9%Q3 2022
IMNMImmunome Inc.$37.2M1.41%1.50%+5.2%Q1 2024
NKTRNektar Therapeutics$36.7M1.39%2.50%+16.2%Q3 2025
AXSMAxsome Therapeutics, Inc.$36M1.37%0.41%+1634.4%Q1 2020
IMTXImmatics N.V.$35.7M1.36%2.71%+5.7%Q3 2020
BBIOBridgeBio Pharma, Inc.$30.4M1.15%0.21%-43.2%Q1 2025
DYNDyne Therapeutics, Inc.$29.6M1.13%0.99%-27.5%Q2 2023
INBXInhibrx Biosciences, Inc.$27.3M1.04%2.78%-10.7%Q4 2021
DXCMDexcom Inc$24.7M0.94%0.10%+4.1%Q1 2021
PHVSPharvaris N.V.$23.1M0.88%1.25%+9.8%Q4 2023
PRAXPraxis Precision Medicines, Inc.$20.5M0.78%0.23%-49.4%Q1 2025
GMABGenmab A/S$20.2M0.77%Not reportedNewQ1 2026
RCUSArcus Biosciences, Inc.$19.9M0.76%0.74%-15.8%Q4 2020
XENEXenon Pharmaceuticals Inc.$17.7M0.67%0.32%+409.5%Q4 2025
SYKStryker Corp$14.6M0.56%0.01%Not reportedQ3 2023
ANABAnaptysbio, Inc$13.8M0.52%0.86%-13.7%Q3 2018
ROIVRoivant Sciences Ltd.$13.2M0.50%0.07%-34.9%Q1 2024
EWTXEdgewise Therapeutics, Inc.$12.2M0.46%0.36%-11.7%Q2 2024
CMPXCompass Therapeutics, Inc.$10.9M0.41%1.14%-38.9%Q3 2025
ORICOric Pharmaceuticals, Inc.$8.61M0.33%0.66%Not reportedQ2 2020
TNGXTango Therapeutics, Inc.$8.27M0.31%0.27%NewQ1 2026
TYRATyra Biosciences, Inc.$7.81M0.30%0.34%NewQ1 2026
AXGNAxogen, Inc.$6.98M0.27%0.40%NewQ1 2026
DFTXDefinium Therapeutics, Inc.$6.5M0.25%0.33%NewQ1 2026
CYTKCytokinetics Inc$6.05M0.23%0.07%Not reportedQ3 2019
IRONDisc Medicine, Inc.$5.01M0.19%0.21%-29.5%Q1 2024
MANEVeradermics, Inc$4.63M0.18%0.20%NewQ1 2026
HRMYHarmony Biosciences Holdings, Inc.$4.28M0.16%0.26%NewQ1 2026
PCVXVaxcyte, Inc.$2.94M0.11%0.04%NewQ1 2026
MIRMMirum Pharmaceuticals, Inc.$2.55M0.10%0.05%+19.4%Q1 2020
NXTCNextCure, Inc.$2.38M0.09%6.17%Not reportedQ2 2019
SVRASavara Inc$1.99M0.08%0.18%+19.7%Q2 2018
Q4 2025Reported Feb 13, 202660 positions
NTRANatera, Inc.$355M15.31%1.11%Not reportedQ1 2018
JAZZJazz Pharmaceuticals plc$163M7.04%1.56%+63.0%Q2 2020
AZNAstrazeneca PLC$150M6.47%Not reported+98.1%Q1 2018
VERAVera Therapeutics, Inc.$141M6.10%4.37%Not reportedQ2 2021
BMYBristol Myers Squibb Co$81.6M3.52%0.07%Not reportedQ1 2018
UTHRUNITED THERAPEUTICS Corp$76.8M3.31%0.36%-17.3%Q3 2019
VRTXVertex Pharmaceuticals Inc / Ma$74.6M3.22%0.06%+39.6%Q2 2019
ABBVAbbVie Inc.$72.6M3.13%0.02%+110.5%Q2 2019
ISRGIntuitive Surgical Inc$71.9M3.10%0.04%+14.5%Q3 2022
COGTCogent Biosciences, Inc.$70.1M3.02%1.23%-7.3%Q1 2024
LLYELI LILLY & Co$66.3M2.86%0.01%Not reportedQ2 2020
RAPPRapport Therapeutics, Inc.$57.8M2.49%3.99%-2.2%Q2 2024
BBIOBridgeBio Pharma, Inc.$55.1M2.38%0.37%-13.4%Q1 2025
RNAMAvidity Biosciences, Inc.$53.7M2.32%0.49%-14.9%Q2 2024
DYNDyne Therapeutics, Inc.$44.1M1.90%1.37%+128.7%Q2 2023
BMRNBiomarin Pharmaceutical Inc$41.4M1.79%0.36%Not reportedQ4 2018
APGEApogee Therapeutics, Inc.$40.4M1.74%0.78%-5.4%Q2 2025
CDTXCidara Therapeutics, Inc.$39.8M1.72%0.57%+232.6%Q1 2018
PRAXPraxis Precision Medicines, Inc.$37.1M1.60%0.50%-27.3%Q1 2025
IMTXImmatics N.V.$36.1M1.56%2.56%+54.2%Q3 2020
INBXInhibrx Biosciences, Inc.$35.9M1.55%3.12%+3.3%Q4 2021
IMNMImmunome Inc.$34.8M1.50%1.43%+271.2%Q1 2024
AVBPArriVent BioPharma, Inc.$34.1M1.47%4.00%Not reportedQ1 2024
GKOSGLAUKOS Corp$32.5M1.40%0.50%-7.9%Q3 2025
IDYAIDEAYA Biosciences, Inc.$30.6M1.32%1.01%-4.1%Q3 2022
BIOABioAge Labs, Inc.$30.3M1.31%6.14%Not reportedQ3 2024
CELCCelcuity Inc.$29.9M1.29%0.62%+18.2%Q3 2025
RYTMRhythm Pharmaceuticals, Inc.$29.1M1.25%0.40%+9.9%Q2 2018
CNTACentessa Pharmaceuticals PLC$27.6M1.19%0.74%NewQ4 2025
SUPNSupernus Pharmaceuticals, Inc.$27.5M1.19%0.96%+46.7%Q2 2020
INSMINSMED Inc$27.3M1.18%0.07%+50.3%Q1 2019
ALCAlcon Inc$26.2M1.13%0.07%NewQ4 2025
RCUSArcus Biosciences, Inc.$26.1M1.13%0.88%-10.3%Q4 2020
DXCMDexcom Inc$25.1M1.08%0.10%-51.5%Q1 2021
PHVSPharvaris N.V.$20.7M0.89%1.14%+0.7%Q4 2023
NKTRNektar Therapeutics$18.5M0.80%2.15%+270.4%Q3 2025
CMPXCompass Therapeutics, Inc.$18.1M0.78%1.89%+65.9%Q3 2025
ROIVRoivant Sciences Ltd.$15.9M0.69%0.10%-76.7%Q1 2024
ANABAnaptysbio, Inc$13.9M0.60%1.03%+13.1%Q3 2018
GEHCGE HealthCare Technologies Inc.$13.2M0.57%0.04%+6.5%Q3 2025
EWTXEdgewise Therapeutics, Inc.$10.9M0.47%0.41%-15.8%Q2 2024
EXKEndeavour Silver Corp$10.3M0.44%0.04%-72.2%Q1 2024
IRONDisc Medicine, Inc.$8.82M0.38%0.29%+719.1%Q1 2024
AMLXAmylyx Pharmaceuticals, Inc.$6.37M0.27%0.48%Not reportedQ1 2022
MASIMasimo Corp$6.01M0.26%0.09%Not reportedQ4 2023
QUREuniQure N.V.$4.22M0.18%0.28%+29.0%Q1 2021
NXTCNextCure, Inc.$3.16M0.14%6.35%Not reportedQ2 2019
WVEWave Life Sciences, Inc.$2.69M0.12%0.08%-7.5%Q2 2025
XENEXenon Pharmaceuticals Inc.$2.68M0.12%0.07%NewQ4 2025
EVMNEvommune, Inc.$2.62M0.11%0.49%NewQ4 2025
Q3 2025Reported Nov 14, 202555 positions
NTRANatera, Inc.$250M13.65%1.13%Not reportedQ1 2018
GILDGilead Sciences, Inc.$139M7.60%0.10%+19.2%Q4 2018
VERAVera Therapeutics, Inc.$81.2M4.44%4.38%Not reportedQ2 2021
UTHRUNITED THERAPEUTICS Corp$79.9M4.37%0.44%+60.9%Q3 2019
JAZZJazz Pharmaceuticals plc$77.6M4.24%0.97%-15.2%Q2 2020
AZNAstrazeneca PLC$63.2M3.46%Not reported+180.6%Q1 2018
RAPPRapport Therapeutics, Inc.$57.8M3.16%4.09%-2.4%Q2 2024
BSXBoston Scientific Corp$55.6M3.04%0.04%+32.1%Q2 2023
DXCMDexcom Inc$52.5M2.87%0.20%+48.9%Q1 2021
ISRGIntuitive Surgical Inc$49.6M2.71%0.03%+57.0%Q3 2022
AXSMAxsome Therapeutics, Inc.$47.8M2.61%0.78%+320.4%Q1 2020
ROIVRoivant Sciences Ltd.$47.6M2.61%0.46%+2.0%Q1 2024
VRTXVertex Pharmaceuticals Inc / Ma$46.2M2.52%0.05%Not reportedQ2 2019
BBIOBridgeBio Pharma, Inc.$43.2M2.36%0.43%-16.2%Q1 2025
RNAMAvidity Biosciences, Inc.$38.2M2.09%0.60%+49.8%Q2 2024
ABBVAbbVie Inc.$35M1.91%0.01%-43.2%Q2 2019
AVBPArriVent BioPharma, Inc.$31.3M1.71%4.15%Not reportedQ1 2024
COGTCogent Biosciences, Inc.$30.6M1.67%1.52%-9.7%Q1 2024
GKOSGLAUKOS Corp$25.5M1.40%0.55%NewQ3 2025
IDYAIDEAYA Biosciences, Inc.$25.1M1.37%1.05%-57.0%Q3 2022
RYTMRhythm Pharmaceuticals, Inc.$24.9M1.36%0.37%-57.9%Q2 2018
AKROAkero Therapeutics, Inc.$22.5M1.23%0.59%-13.7%Q1 2020
APGEApogee Therapeutics, Inc.$22.5M1.23%0.95%+642.2%Q2 2025
EXKEndeavour Silver Corp$20M1.09%0.14%+75.2%Q1 2024
IMTXImmatics N.V.$19M1.04%1.83%-0.6%Q3 2020
PHVSPharvaris N.V.$18.5M1.01%1.36%+26.4%Q4 2023
SUPNSupernus Pharmaceuticals, Inc.$18M0.99%0.66%-52.8%Q2 2020
RCUSArcus Biosciences, Inc.$16.6M0.91%1.14%+0.5%Q4 2020
MRUSMerus N.V.$15.7M0.86%0.22%-58.8%Q1 2018
INSMINSMED Inc$15M0.82%0.05%-66.8%Q1 2019
INBXInhibrx Biosciences, Inc.$14.8M0.81%3.04%-37.9%Q4 2021
BIOABioAge Labs, Inc.$13.5M0.74%6.40%-0.5%Q3 2024
CELCCelcuity Inc.$12.5M0.68%0.59%NewQ3 2025
DYNDyne Therapeutics, Inc.$12.5M0.68%0.69%+60.3%Q2 2023
PTCTPTC Therapeutics, Inc.$11.5M0.63%0.23%-50.3%Q1 2018
GEHCGE HealthCare Technologies Inc.$11.3M0.62%0.03%NewQ3 2025
SLNOSoleno Therapeutics Inc$11.2M0.61%0.31%-60.0%Q4 2023
PRAXPraxis Precision Medicines, Inc.$9.16M0.50%0.82%+999.7%Q1 2025
SVRASavara Inc$8.67M0.47%1.40%-1.2%Q2 2018
EWTXEdgewise Therapeutics, Inc.$8.44M0.46%0.49%-27.4%Q2 2024
QUREuniQure N.V.$7.99M0.44%0.22%-91.2%Q1 2021
ANABAnaptysbio, Inc$7.79M0.43%0.92%-75.4%Q3 2018
CMPXCompass Therapeutics, Inc.$7.1M0.39%1.14%NewQ3 2025
NKTRNektar Therapeutics$6.74M0.37%0.60%NewQ3 2025
CDTXCidara Therapeutics, Inc.$5.19M0.28%0.18%-78.4%Q1 2018
IMNMImmunome Inc.$5.11M0.28%0.48%-44.0%Q1 2024
NXTCNextCure, Inc.$1.3M0.07%8.32%0.0%Q2 2019
WVEWave Life Sciences, Inc.$1.25M0.07%0.11%+45.0%Q2 2025
SRRKScholar Rock Holding Corp$1.17M0.06%0.03%+18.8%Q1 2025
JBIOJade Biosciences, Inc.$927K0.05%0.33%Not reportedQ2 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.